Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Amazon is Considering a $9 Billion Deal to Acquire Satellite Communications Company Globalstar. Here′s Why... (Fool) +++ GLOBALSTAR Aktie +3,82%

EUROFINS Aktie

 >EUROFINS Aktienkurs 
66.68 EUR    +2.5%    (TradegateBSX)
Ask: 67.24 EUR / 80 Stück
Bid: 66.82 EUR / 80 Stück
Tagesumsatz: 1425 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
EUROFINS Aktie über LYNX handeln
>EUROFINS Performance
1 Woche: +8,8%
1 Monat: -1,9%
3 Monate: +7,4%
6 Monate: +6,3%
1 Jahr: +38,9%
laufendes Jahr: +6,9%
>EUROFINS Aktie
Name:  EUROFINS SCIENTIFIC SE
Land:  Frankreich
Sektor:  Gesundheit
ISIN/ Wkn:  FR0014000MR3 / A2QJCT
Symbol/ Ticker:  ESF0 (Frankfurt)
Kürzel:  FRA:ESF0, ETR:ESF0, ESF0:GR
Index:  CAC40
Webseite:  https://www.eurofins.com/
Profil:  Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, specializing in testing and support services across multiple industries. It delivers comprehensive analytical solutions to the pharmaceutical, food, environmental, ..
>Volltext..
Marktkapitalisierung:  11445.35 Mio. EUR
Unternehmenswert:  16117.43 Mio. EUR
Umsatz:  7423.75 Mio. EUR
EBITDA:  1568.16 Mio. EUR
Nettogewinn:  483.11 Mio. EUR
Gewinn je Aktie:  2.69 EUR
Schulden:  5527.03 Mio. EUR
Liquide Mittel:  805.04 Mio. EUR
Operativer Cashflow:  1316.74 Mio. EUR
Bargeldquote:  0.33
Umsatzwachstum:  4.96%
Gewinnwachstum:  16.83%
Dividende je Aktie:  0.6 EUR
Dividendenrendite:  0.97%
Dividendenschätzung:  1.17%
Div. Historie:  28.04.25 - 0.6€
03.07.24 - 0.5€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  EUROFINS
Letzte Datenerhebung:  03.04.26
>EUROFINS Kennzahlen
Aktien/ Unternehmen:
Aktien: 176.7 Mio. St.
Frei handelbar: 61.62%
Leerverk. Aktien: -
Rückkaufquote: 1.28%
Mitarbeiter: 65694
Umsatz/Mitarb.: 0.11 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 10.11%
Bewertung:
KGV: 25.57
KGV lG: 17.13
KUV: 1.65
KBV: 3.25
PEG-Ratio: 1.17
EV/EBITDA: 10.28
Rentabilität:
Bruttomarge: 11.22%
Gewinnmarge: 6.51%
Operative Marge: 11.22%
Managementeffizenz:
Gesamtkaprendite: 4.34%
Eigenkaprendite: 12.05%
 >EUROFINS Anleihen 
>EUROFINS Peer Group
Gesundheit
 
03.04.26 - 15:24
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name VIGNEAU François 2. Reason for the notification a) Position / status Senior Vice President b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57   4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (i...
03.04.26 - 12:00
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 2. Identity of the notifier (if another person makes the notification on behalf of the issuer) N/A 3. Total number of shares composing the share capital of the notifying issuer 176,000,000 4. Total number of voting rights attached to the shares composing the share capital of the notifying issuer, including the suspended voting rightsii 365,011,719 5. Origin of the changeiii Reduction in number of shares: Cancellation of 6,163,000 shares Reduction in numbers of voting rights: Cancellation of some class A beneficiary units P...
02.04.26 - 10:03
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name Timothy Scott Oostdyck 2. Reason for the notification a) Position / status Member of Group Operating Council b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57   4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transac...
01.04.26 - 07:21
Eurofins Announces the Cancellation of 6.163M Repurchased Shares (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (the “Company” or “Eurofins”) (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 6,163,000 shares, representing 3.38% of the Company's share capital, that were repurchased as part of its share buyback programmes, which began in October 2022. The cancellation of shares is in line with, among other objectives, the Company's intention to reduce the share capital as authorised by shareholders at the Annual General Meeting held on 24 April 2025. Following this cancellation of repurchased shares, which is effective as of 31 March 2026, the total number of Eurofins shares outstanding is now 176,000,000. About Eurofins – the global leader in bio-analysis Eurofins is Testing for Life. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanc...
31.03.26 - 15:36
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 52990...
30.03.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases from 23th March to 27th March 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 23/03/2026 FR0014000MR3 48 000 61.1218 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 23/03/2026 FR0014000MR3 12 000 61.2959 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/03/2026 FR0014000MR3 43 000 61.1757 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/03/2026 FR0014000MR3 7 000 61.2332 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/03/2026 FR0014000MR3 7 000 61.8379 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/03/2026 FR0014000MR3 43 000 61.7989 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/03/2026 FR0014000MR3 43 000 62.0870 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/03/2026 FR0014000MR3 7 000 62.1700 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 27/0...
26.03.26 - 15:06
Eurofins Viracor Launches ExPeCT™ anti-CD19 (obe-cel) CAR T-Cell Assay to Advance Proactive Monitoring in Next-Generation Immunotherapy (PR Newswire)
 
LENEXA, Kan., March 26, 2026 /PRNewswire/ -- Eurofins Viracor, a leader in advanced clinical diagnostics, today announced the launch of the ExPeCT™ anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with......
26.03.26 - 14:12
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name VIGNEAU François     2. Reason for the notification a) Position / status Senior Vice President b) Initial notification / amendment Initial     3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57       4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type ...
23.03.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases From 16th March to 20th March 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 16/03/2026 FR0014000MR3 50 000 61.5297 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 17/03/2026 FR0014000MR3 50 000 61.8165 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 18/03/2026 FR0014000MR3 40 000 62.7347 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 18/03/2026 FR0014000MR3 10 000 62.7318 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 19/03/2026 FR0014000MR3 9 650 61.6796 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 19/03/2026 FR0014000MR3 40 350 61.6345 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 20/03/2026 FR0014000MR3 44 000 61.7853 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 20/03/2026 FR0014000MR3 6 000 61.7567 CEUX TOTAL 250 000 61.9011   Transaction details...
23.03.26 - 17:12
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Va Fleuri, L-1526 Luxembourg   2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial   3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI ...
23.03.26 - 07:18
Eurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the Bondholders (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Disclaimer: this document is a non-binding English translation of the convening notice of the shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting to be held on Thursday 23 April 2026 – the French version of the convening notice (“avis de convocation des actionnaires à l'assemblée générale ordinaire annuelle et une assemblée générale extraordinaire de la Société valant avis d'information des obligataires”) is the only official version. For the avoidance of doubt, in case of discrepancies between the French and the English version, the French version shall always prevail. EUROFINS SCIENTIFIC SE Société Européenne Registered office: 23, Val Fleuri, L-1526 Luxembourg Registre de Commerce et des Sociétés Luxembourg: B167775 (the “Company”) The shareholders of the Company, and only with a consultative vote the holders of Deeply Subordinated Fixed to Floating Rate Bonds (ISIN: XS2579...
16.03.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases From 09th March to 13th March 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 09/03/2026 FR0014000MR3 10 000 63.1848 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 09/03/2026 FR0014000MR3 30 000 63.1292 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/03/2026 FR0014000MR3 30 000 64.2626 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/03/2026 FR0014000MR3 10 000 64.2183 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 11/03/2026 FR0014000MR3 10 000 63.2106 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 11/03/2026 FR0014000MR3 30 000 63.1997 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/03/2026 FR0014000MR3 40 000 62.4756 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/03/2026 FR0014000MR3 50 000 61.1391 XPAR       TOTAL 210 000 62.7612   Transaction details In...
10.03.26 - 12:57
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study (GlobeNewswire EN)
 
Raanana, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a Good Manufacturing Practice (GMP) batch of clinical trial material (CTM) for its lead product candidate....
09.03.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd March to 06th March 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 30 000 67.7739 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 10 000 67.7248 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/03/2026 FR0014000MR3 30 000 66.5836 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/03/2026 FR0014000MR3 10 000 66.5204 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 04/03/2026 FR0014000MR3 30 000 66.7649 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 04/03/2026 FR0014000MR3 10 000 66.7647 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 05/03/2026 FR0014000MR3 10 000 66.2541 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 05/03/2026 FR0014000MR3 30 000 66.3290 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 0...
02.03.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases from 23rd February to 27th February 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 23/02/2026 FR0014000MR3 30 000 66.9618 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 23/02/2026 FR0014000MR3 10 000 66.9085 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/02/2026 FR0014000MR3 10 000 66.9007 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/02/2026 FR0014000MR3 30 000 66.8455 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/02/2026 FR0014000MR3 10 000 67.3610 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/02/2026 FR0014000MR3 30 000 67.3045 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/02/2026 FR0014000MR3 10 000 67.2653 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/02/2026 FR0014000MR3 30 000 67.2336 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 2...
26.02.26 - 07:21
Eurofins announces the publication of its 2025 Annual Report and 2025 Environmental, Social and Governance Report (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) has filed its 2025 Annual Report and its 2025 Environmental, Social and Governance Report for the year ended 31 December 2025 with the electronic database of the Luxembourg Stock Exchange (www.bourse.lu) on 26 February 2026. They are available on the Eurofins website, www.eurofins.com, under the heading Investors / Results and Presentations. The Annual Report contains: The Management Report The Remuneration Report The Corporate Governance Report The Audited Annual Financial Statements Notes to Editors: For more information, please visit www.eurofins.com. About Eurofins – the global leader in bio-analysis Eurofins is Testing for Life. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is also one of the market leade...
23.02.26 - 17:51
Eurofins Scientific SE: Weekly Report on Share Repurchases from 16th February to 20th February 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 16/02/2026 FR0014000MR3 30 000 64.6700 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 16/02/2026 FR0014000MR3 10 000 64.7116 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 17/02/2026 FR0014000MR3 40 000 65.8630 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 18/02/2026 FR0014000MR3 10 000 67.0861 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 18/02/2026 FR0014000MR3 30 000 66.9915 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 19/02/2026 FR0014000MR3 29 853 67.3868 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 19/02/2026 FR0014000MR3  147 68.2390 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 20/02/2026 FR0014000MR3 30 000 67.4653 XPAR       TOTAL 180 000 66.3779   Transact...
16.02.26 - 18:24
Eurofins Scientific : Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529...
16.02.26 - 17:51
Eurofins: Weekly Report on Share Repurchases From 09th February to 13th February 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 09/02/2026 FR0014000MR3 10 000 67.5833 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/02/2026 FR0014000MR3 15 000 67.4325 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 11/02/2026 FR0014000MR3 30 000 66.2403 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 11/02/2026 FR0014000MR3 10 000 66.0977 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/02/2026 FR0014000MR3 10 000 64.1236 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/02/2026 FR0014000MR3 30 000 64.1736 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/02/2026 FR0014000MR3 10 000 65.4891 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/02/2026 FR0014000MR3 30 000 65.4570 XPAR       TOTAL 145 000 65.6590 Transaction details In ac...
10.02.26 - 16:51
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name HILL Gavin 2. Reason for the notification a) Position / status Director b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57   4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; an...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Geizige Minister schaden dem Fürsten - allein sie sind unvermeidlich. - Königin Christine von Schweden
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!